Peter Rubinstein Buys 2,200,000 Shares of Digitalx Ltd (ASX:DCC) Stock

Share on StockTwits

Digitalx Ltd (ASX:DCC) insider Peter Rubinstein purchased 2,200,000 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was purchased at an average price of A$0.03 ($0.02) per share, for a total transaction of A$59,400.00 ($42,127.66).

Shares of Digitalx stock remained flat at $A$0.03 ($0.02) during trading on Thursday. The stock had a trading volume of 1,152,697 shares. The company has a market cap of $18.48 million and a P/E ratio of -6.20. The business’s 50 day simple moving average is A$0.04 and its two-hundred day simple moving average is A$0.05. Digitalx Ltd has a 12 month low of A$0.04 ($0.03) and a 12 month high of A$0.11 ($0.07). The company has a quick ratio of 4.43, a current ratio of 10.30 and a debt-to-equity ratio of 2.60.

About Digitalx

DigitalX Limited develops software products in Australia. It provides corporate and investment advisory, tech due diligence and consulting, and marketing and promotional material services; and security and software development consulting services for blockchain and cryptocurrency companies. The company was formerly known as Digital CC Limited and changed its name to DigitalX Limited in December 2015.

Featured Article: The primary rules of Elliott Wave theory

Receive News & Ratings for Digitalx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digitalx and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Investment Analysts’ Price Target Changes for October, 14th
Investment Analysts’ Price Target Changes for October, 14th
Civic  Market Cap Achieves $26.92 Million
Civic Market Cap Achieves $26.92 Million
TRAXIA Tops 24-Hour Trading Volume of $207.00
TRAXIA Tops 24-Hour Trading Volume of $207.00
TOP  Price Hits $0.0022
TOP Price Hits $0.0022
Syndax Pharmaceuticals  Stock Rating Upgraded by Zacks Investment Research
Syndax Pharmaceuticals Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America  Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America Stock Rating Upgraded by Zacks Investment Research


 
© 2006-2019 Zolmax.